Albuquerque R, Khan Z, Poveda A, Higham J, Richards A, Monteiro L, Jan-Salas E, Lopez-Lopez J, Warnakulasuriya S. Management of oral Graft versus Host Disease with topical agents: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e72-81. 

 

 

doi:10.4317/medoral.20968

http://dx.doi.org/doi:10.4317/medoral.20968

 

 

1. Billingham RE, Hings IM. The H-Y antigen and its role in natural transplantation. Hum Genet. 1981;58:9-17.
http://dx.doi.org/10.1007/BF00284141

 

2. Mays J, Fassil H, Edwards D, Pavletic S, Bassim C. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19;327-46.
http://dx.doi.org/10.1111/odi.12028

 

3. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2015;21:389-401.
http://dx.doi.org/10.1016/j.bbmt.2014.12.001

 

4. Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am. 2008;52:79-109.
http://dx.doi.org/10.1016/j.cden.2007.10.004

 

5. Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral graft-versus-host disease. Oral Dis. 2008;14:396-412.
http://dx.doi.org/10.1111/j.1601-0825.2008.01448.x

 

6. Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H, et al. International Consensus Conference on Clinical Practice in cGVHD. Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig. 2011;15:127-39.
http://dx.doi.org/10.1007/s00784-010-0450-6

 

7. Garg AX, Hackam D, Tonelli M. Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol. 2008;3:253-60.
http://dx.doi.org/10.2215/CJN.01430307

 

8. Rossini G, Parrini S, Castroflorio T, Deregibus A, Debernardi CL. Periodontal health during clear aligners treatment: a systematic review. Eur J Orthod. 2015;37:539-43.
http://dx.doi.org/10.1093/ejo/cju083

 

9. Bondemark L, Holm A, Hansen K, Axelsson S, Mohlin B, Brattstrom V. Long-term stability of orthodontic treatment and patient satisfaction. A systematic review. Angle Orthod. 2007;77,181-91.
http://dx.doi.org/10.2319/011006-16R.1

 

10. Elad S, Zeevi I, Finke J, Koldehoff M, Schwerdtfeger R, Wolff D, et al. Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study. Biol Blood Marrow Transplant. 2012;18:134-40.
http://dx.doi.org/10.1016/j.bbmt.2011.06.001

 

11. Noce CW, Gomes A, Shcaira V, Corra ME, Moreira MC, Silva Jnior A, et al. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1163-8.
http://dx.doi.org/10.1016/j.bbmt.2014.04.009

 

12. Epstein JB, Reece DE. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease. Bone Marrow Transplant. 1994;13:81-6.

 

13. Mawardi H, Stevenson K, Gokani B, Soiffer R, Treister N. Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD. Bone Marrow Transplant. 2010;45:1062-7.
http://dx.doi.org/10.1038/bmt.2009.301

 

14. Albert MH, Becker B, Schuster FR, Klein B, Binder V, Adam K, et al. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment. Pediatr Transplant. 2007;11:306-11.
http://dx.doi.org/10.1111/j.1399-3046.2006.00666.x

 

15. Park AR, La HO, Cho BS, Kim SJ, Lee BK, Rhie JY, et al. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease. Am J Health Syst Pharm. 2013;70:1383-91.
http://dx.doi.org/10.2146/ajhp120567

 

16. Sari I, Altuntas F, Kocyigit I, Sisman Y, Eser B, Unal A, et al. The effect of budesonide mouthwash on oral chronic graft versus host disease. Am J Hematol. 2007;82:349-56.
http://dx.doi.org/10.1002/ajh.20814

 

17. Epstein JB, Gorsky M, Epstein MS, Nantel S. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:56-61.
http://dx.doi.org/10.1067/moe.2001.111130

 

18. Conrotto D, Broccoletti R, Carcieri P, Giaccone L, Arduino PG. Topical tacrolimus and periodontal therapy in the management of a case of oral chronic GVHD characterized by specific gingival localization. Case Rep Dent. 2014;2014:127219.
http://dx.doi.org/10.1155/2014/127219

 

19. Brown RS, Edwards D, Walsh-Chocolaad T, Childs RW. Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:e26-30.
http://dx.doi.org/10.1016/j.oooo.2012.07.487

 

20. Rojas AG, Gonzlez GN, Venables GC, Araos HD. [Gran versus host disease with oral involvement: report of one case]. Rev Med Chil. 2008;136:1570-3.
http://dx.doi.org/10.4067/S0034-98872008001200010

 

21. Fricain JC, Sibaud V, Swetyenga N, Tabrizi R, Campana F, Taeb A. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. Br J Dermatol. 2007;156:588-90.
http://dx.doi.org/10.1111/j.1365-2133.2006.07679.x

 

22. Conrotto D, Carrozzo M, Ubertalli AV, Gandolfo S, Giaccone L, Boccadoro M, et al. Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease. Transplantation. 2006;82:1113-5.
http://dx.doi.org/10.1097/01.tp.0000232287.08903.1d

 

23. Eckardt A, Starke O, Stadler M, Reuter C, Hertenstein B. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncol. 2004;40:811-4.
http://dx.doi.org/10.1016/j.oraloncology.2004.02.003

 

24. Snchez AR, Sheridan PJ, Rogers RS. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. J Periodontol. 2004;75:613-9.
http://dx.doi.org/10.1902/jop.2004.75.4.613

 

25. St John L, Gordon SM, Childs R, Marquesen M, Pavletic SZ, Wu TX, et al. Topical thalidomide gel in oral chronic GVHD and role of in situ cytokine expression in monitoring biological activity. Bone Marrow Transplant. 2013;48:610-1.
http://dx.doi.org/10.1038/bmt.2012.178

 

26. Zadik Y, Nakdimon I, Meyerowitz C, Shapira MY, Elad S. Topical budesonide for severe oral chronic graft-versus-host disease. Am J Health Syst Pharm. 2014;71:181-2.
http://dx.doi.org/10.2146/ajhp130520

 

27. Dechartres A, Boutron I, Roy C, Ravaud P. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal. J Clin Epidemiol. 2009;62:695-702.
http://dx.doi.org/10.1016/j.jclinepi.2008.09.011

 

28. Kahan BC, Cro S, Dor CJ, Bratton DJ, Rehal S, Maskell NA, et al. Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials. Trials. 2014;15:456.
http://dx.doi.org/10.1186/1745-6215-15-456

 

29. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
http://dx.doi.org/10.1371/journal.pmed.1000097

 

30. Dilger K, Halter J, Bertz H, Lopez-Lazaro L, Gratwohl A, Finke J. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2009;15:336-43.
http://dx.doi.org/10.1016/j.bbmt.2008.12.001

 

31. Elad S, Jensen SB, Raber-Durlacher JE, Mouradian N, Correa EM, Schubert MM, et al. Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support Care Cancer. 2015;23:1615-22.
http://dx.doi.org/10.1007/s00520-014-2503-x

 

32. Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995;17:584-91.
http://dx.doi.org/10.1097/00007691-199512000-00007

 

33. Thomson MA, Hamburger J, Stewart DG, Lewis HM. Treatment of erosive oral lichen planus with topical tacrolimus. J Dermatolog Treat. 2004;15:308-14.
http://dx.doi.org/10.1080/09546630410018247

 

34. Thongprasom K, Chaimusig M, Korkij W, Sererat T, Luangjarmekorn L, Rojwattanasirivej S. A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus. J Oral Pathol Med. 2007;36:142-6.
http://dx.doi.org/10.1111/j.1600-0714.2007.00510.x

 

35. Mawardi H, Elad S, Correa ME, Stevenson K, Woo SB, Almazrooa S, et al. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant. 2011;46:884-91.
http://dx.doi.org/10.1038/bmt.2011.77

 

36. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Soce G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897-904.
http://dx.doi.org/10.1056/NEJM199703273361301

 

37. Elad S, Or R, Garfunkel AA, Shapira MY. Budesonide: a novel treatment for oral chronic graft versus host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:308-11.
http://dx.doi.org/10.1067/moe.2003.23

 

38. Van Schandevyl G, Bauters T. Formulation of budesonide mouthwash for the treatment of oral chronic graft-versus-host disease. J Oncol Pharm Pract. 2014;pii: 1078155214560654. [Epub ahead of print].

 

39. Thongprasom K, Carrozzo M, Furness S, Lodi G. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011;7:CD001168.
http://dx.doi.org/10.1002/14651858.cd001168.pub2

 

40. Carbone M, Arduino PG, Carrozzo M, Caiazzo G, Broccoletti R, Conrotto D, et al. Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J Oral Pathol Med. 2009;38:227-33.
http://dx.doi.org/10.1111/j.1600-0714.2008.00688.x